Efficacy and Safety of Vildagliptin in Combination With Metformin in Patients With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 04 Aug 2017
At a glance
- Drugs Vildagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 01 May 2012 Actual end date (September 2005) added as reported by ClinicalTrials.gov.
- 01 May 2012 Actual initiation date (May 2004) added as reported by ClinicalTrials.gov.
- 01 May 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History